2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
January 21st, 2025
Version: 1
Department of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA ; Kavli Neuroscience Discovery Institute, John
bioengineering
biorxiv

Multi-Region Brain Organoid: Fusion Organoid with Cerebral, Endothelial and Mid-Hindbrain Components

Kshirsagar, A.Open in Google Scholar•Mnatsakanyan, H.Open in Google Scholar•Kulkarni, S.Open in Google Scholar•Guo, J.Open in Google Scholar•Cheng, K.Open in Google Scholar•Bohra, O.Open in Google Scholar•Badr, C. E.Open in Google Scholar•Kathuria, A.Open in Google Scholar

Brain organoid technology has revolutionized our ability to model human neurodevelopment in vitro. However, current techniques remains limited by their reliance on simplified endothelial cell populations rather than a complete endothelial system. We engineered Multi-Region Brain Organoids (MRBOs) that integrate cerebral, mid/hindbrain, and complex endothelial organoids into one structure. Different from the earlier approaches based on isolated HUVECs, our endothelial organoids contain diverse vascular cell types, including vascular progenitors, mature endothelial cells, pericytes, proliferating angiogenic cells and stromal cells. Our strategy employs a sequential modulation of key developmental pathways to generate individual organoids, followed by optimized fusion conditions that maintain regional identities while supporting cellular integration. Single-nucleus RNA sequencing shows that MRBOs develop discrete neural populations specific to each brain region alongside specialized endothelial populations that establish paracrine signalling networks. Integration analysis with human fetal brain data shows that MRBOs contribute to 80% of cellular clusters found in human fetal brain tissue (Carnegie stages 12-16), whereas CellChat analysis identifies 13 previously uncharacterized endothelial-neural signalling interactions. Notably, we uncover endothelial-derived factors that support the persistence of intermediate progenitor populations during mid/hindbrain development, thereby revealing a new role for complex endothelial populations in regional brain patterning. This effect was not observed in cerebral development. This platform enables matching multiple developmental regions, fully incorporating the endothelial nature at the same time. There are opportunities for studying neurodevelopmental disorders in which neural-endothelial interactions are disrupted. Our engineered MRBO system establishes a foundation for investigating complex neurodevelopmental processes, providing an enabling context closer to physiological relevance.

Similar Papers

biorxiv
Fri Jul 04 2025
Estimating the contribution of musculoskeletal impairments to altered gait kinematics in children with cerebral palsy using predictive simulations
Background: Cerebral palsy (CP) is caused by a brain lesion around birth leading to impaired motor control, bony deformities, muscle contractures, and weakness resulting in altered gait. Since the brain lesion cannot be cured, treatment aims at improving mobility. Multilevel surgery targets muscle and bony impairments but the outcome of multilevel surgery is variable and unpredictable due to our l...
Van Den Bosch, B.
•
D'Hondt, L.
•
Jonkers, I.
•
Desloovere, K.
...•
De Groote, F.
biorxiv
Fri Jul 04 2025
MagPiezo: a Magnetogenetic Platform for Remote Activation of Endogenous Piezo1 Channels in Endothelial Cells
This work introduces MagPiezo, a novel magnetogenetic platform designed to enable remote and targeted manipulation of endogenous Piezo1 channels without genetic modification. MagPiezo integrates a custom-built magnetic applicator and 19 nm octahedral mixed ferrite nanoparticles (MFs) with enhanced magnetocrystalline anisotropy, engineered to selectively target Piezo1 channels. The application of a...
Del Sol-Fernandez, S.
•
De Simone, M.
•
Fernandez-Afonso, Y.
•
Garcia-Gonzalez, D.
...•
Moros, M.
biorxiv
Fri Jul 04 2025
Genipin-Crosslinked, Silane-Anchored 3D Tumor-Stroma Microtissues for High-Content On-Chip Drug Testing
Physiologically relevant 3D tumor models incorporating extracellular matrix (ECM) and cancer-associated fibroblasts (CAFs) are essential for studying tumor progression and drug resistance yet often suffer from hydrogel contraction and instability - especially in microfluidic formats, where ECM deformation hampers long-term culture and quantitative imaging. Here, we present a microfluidic tumor-str...
Le Manach, D.
•
Kowsari-Esfahan, R.
•
Reszczynska, E.
•
Nghe, P.
•
Nees, M.
biorxiv
Fri Jul 04 2025
Antimicrobial Loaded Graft-Copolymer Nanoparticles for Treatment of Pseudomonas aeruginosa Infections
Nearly 80% of cystic fibrosis patients are affected by persistent lung infections, with Pseudomonas aeruginosa being one of the major culprits. Treatment of P. aeruginosa is further complicated by its ability to form biofilms. Anionic compounds within the biofilm and thick cystic fibrosis mucus interact with cationic antimicrobials, hindering treatment efficacy. In this study, we investigated the ...
Soler, Y. V.
•
Xu, W.
•
Lima, M. R. N.
•
McDonald, J.
...•
Roth, C. M.
biorxiv
Fri Jul 04 2025
Distinguishing Protein and Gene Delivery Enables Characterization and Bioengineering of Extracellular Vesicle-Adeno-Associated Virus Vectors
Adeno-associated virus (AAV) gene therapies have achieved clinical success, with multiple products reaching regulatory approval. Encapsulation of AAV vectors within engineered extracellular vesicles (EVs) is an emerging strategy which could help overcome challenges including pre-existing anti-capsid immunity and the need for controlling targeting and tropism. To guide the development of EV-AAV tec...
Boucher, J. D.
•
Stranford, D. M.
•
Edelstein, H. I.
•
Tullman-Ercek, D.
...•
Leonard, J. N.
biorxiv
Fri Jul 04 2025
Cryopreservation of siRNA-treated cells is feasible
Cryopreservation is a routine step in the manufacturing process of adoptive cell therapies, providing critical logistic flexibility. RNAi-based therapies are increasingly being explored as enhancers or modulators of adoptive cell therapies. However, the impact of cryopreservation on cells treated with RNAi-based therapies has not been investigated before. In this study, we addressed this knowledge...
Sauer, M.
•
Segarra-Visent, X.
•
Breuer, L.
•
Tzirtziganis, V.
...•
Haraszti, R. A.
biorxiv
Fri Jul 04 2025
In silico model of basal ganglia Deep Brain Stimulation in Parkinsons Disease captures range of effective parameters for pathological beta power suppression
In Parkinsons disease (PD), the beta band ([12 30] Hz) component of basal ganglia activity is pathologically high. Deep brain stimulation (DBS) is an effective treatment to suppress symptoms of PD and is known to suppress pathological beta activity. However, the mechanism underlying this effect is not completely understood. Here, we tested the circuital effects of DBS in a computational model of t...
Ahmadipour, M.
•
Mazzoni, A.
biorxiv
Thu Jul 03 2025
Sealable capped nanovials for high-throughput screening of cell growth and function
Millions of modular nanoliter-scale compartments that isolate functionally rich single-cell and cell-to-cell communication data can scale biological discovery for the age of AI. Here, we introduce capped nanovials; suspendable, sealable microscale compartments formed by the docking of hydrogel capping particles into bowl-shaped nanovials as a versatile system for culturing, analyzing, and sorting ...
Mellody, M. P.
•
Nakagawa, Y.
•
Arnheim, A.
•
Shang, L.
...•
Di Carlo, D.
biorxiv
Thu Jul 03 2025
Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements
Rate-modulating drugs, such as adrenergic agonists and antagonists, are widely used in the treatment of cardiovascular conditions. Preclinical assessment of new rate and metabolism modulators can be augmented through the development of high-throughput (HT) methods that allow chronic measurements. Such approaches are best coupled with human induced pluripotent stem cell-derived cardiomyocytes (hiPS...
Li, W.
•
McLeod, D.
•
Heinson, Y. W.
•
Kay, M. W.
...•
Entcheva, E.
biorxiv
Thu Jul 03 2025
Optimizing automated sleep stage scoring of 5-second mini-epochs: a transfer learning study
Study objective: Conventional sleep staging relies on 30-second epochs, potentially concealing transient sleep stage intrusion and reducing precision. Building on our previous study of mini-epochs, we investigated whether U-Sleep, an existing automatic deep learning-based sleep staging model with high performance in epochs, could be optimized to similar performance level in 5-second mini-epoch sco...
Follin, L. F.
•
Christensen, J. A. E.
•
Vevelstad, J.
•
Juvodden, H. T.
...•
Knudsen-Heier, S.